 |
|
Waist-to-hip ratio may better predict cardiovascular risk than body mass index
August 14, 2007In a study to be published in the Aug. 21 issue of the Journal of the American College of Cardiology, investigators at UT Southwestern Medical Center found that people with a larger waist-to-hip ratio may be at increased risk for heart disease. The research evaluates the association between different measures of obesity and the prevalence of arterial disease.
"Our study shows that people who develop fat around the middle have more atherosclerotic plaque than those who have smaller waist-to-hip ratios," said Dr. James de Lemos, associate professor of internal medicine and senior author of the study. "The risk was the same for both men and women who develop abdominal fat."
Prior studies examining the association between obesity and cardiovascular risk reported varied results for overweight subjects who eventually had clinical cardiovascular events. The patients often were evaluated for obesity on the sole measurement of body mass index (BMI), a weight-to-height ratio commonly used in doctors' offices to gauge obesity. The UT Southwestern findings, however, suggest that BMI alone might not give a clear enough picture of heart disease risk "BMI was used as the primary measure of obesity rather than alternative measures such as waist circumference or waist-to-hip ratio," said Dr. de Lemos. "The latter measures have demonstrated stronger correlations for cardiovascular risk than BMI."
In the UT Southwestern study, researchers looked at men and women between the ages of 18 and 65. Nearly 3,000 individuals participated in a total of three medical visits each, which included an in-home health survey, blood and urine collection, and a detailed clinical exam complete with abdominal magnetic resonance imaging and coronary artery calcium scans.
Calcium was more likely to be found in the arteries of patients with the greatest waist-to-hip ratio, the researchers discovered. People with the largest waist-to-hip ratio had a twofold increase in the incidence of calcium deposits - a strong indicator of future cardiovascular ailments including heart attacks.
The prevalence of coronary artery calcium was strongly associated with waist circumference and waist-to-hip ratio in addition to high BMI. Hip circumference alone, however, was not a strong indicator for coronary calcium deposits. "Fat that accumulates around your waist seems to be more biologically active as it secretes inflammatory proteins that contribute to atherosclerotic plaque buildup, whereas fat around your hips doesn't appear to increase risk for cardiovascular disease at all," Dr. de Lemos said. "We think the key message for people is to prevent accumulation of central fat early on in their lives. To do so, they will need to develop lifelong dietary and exercise habits that prevent the development of the 'pot belly.'"
UT Southwestern Medical Center
In the UT Southwestern study, researchers looked at men and women between the ages of 18 and 65. Nearly 3,000 individuals participated in a total of three medical visits each, which included an in-home health survey, blood and urine collection, and a detailed clinical exam complete with abdominal magnetic resonance imaging and coronary artery calcium scans.
Calcium was more likely to be found in the arteries of patients with the greatest waist-to-hip ratio, the researchers discovered. People with the largest waist-to-hip ratio had a twofold increase in the incidence of calcium deposits - a strong indicator of future cardiovascular ailments including heart attacks.
The prevalence of coronary artery calcium was strongly associated with waist circumference and waist-to-hip ratio in addition to high BMI. Hip circumference alone, however, was not a strong indicator for coronary calcium deposits. "Fat that accumulates around your waist seems to be more biologically active as it secretes inflammatory proteins that contribute to atherosclerotic plaque buildup, whereas fat around your hips doesn't appear to increase risk for cardiovascular disease at all," Dr. de Lemos said. "We think the key message for people is to prevent accumulation of central fat early on in their lives. To do so, they will need to develop lifelong dietary and exercise habits that prevent the development of the 'pot belly.'"
UT Southwestern Medical Center
Cardiovascular Risk Current Events and Cardiovascular Risk News RSSVioxx trial data shows early cardiovascular risk
Evidence of cardiovascular risks associated with taking Vioxx, the popular, nonsteroidal anti-inflammatory drug (rofecoxib), could have been identified nearly four years before its manufacturer, Merck & Co. Inc., voluntarily pulled the drug from the market.
Menopause-cardiology consensus statement on cardiovascular disease and on HRT
A menopause-cardiology consensus statement has called for direct action to prevent cardiovascular disease (CVD) in menopausal women. The statement also concludes that there is little evidence of increased CVD risk in taking HRT.
Diabetes surgery summit consensus lays foundation for new field of medicine
A first-of-its-kind consensus statement on diabetes surgery is published online today in the Annals of Surgery.
Genetic analysis helps dissect molecular basis of cardiovascular disease
Using highly precise measurements of plasma lipoprotein concentrations determined by nuclear magnetic resonance spectroscopy (NMR), researchers led by Daniel Chasman at Brigham and Women's Hospital and Harvard Medical School in Boston, MA, the Framingham Heart Study in Framingham, and the PROCARDIS consortium in Stockholm, Sweden and Oxford, England performed genetic association analysis across the whole genome among 17,296 women of European ancestry from the Women's Genome Health Study.
Night Beat, Overtime and a Disrupted Sleep Pattern Can Harm Officers' Health
A police officer who works the night shift, typically from 8 p.m. to 4 a.m., already is at a disadvantage when it comes to getting a good "night's" sleep.
A decade later, lifestyle changes or metformin still lower type 2 diabetes risk
Intensive lifestyle changes aimed at modest weight loss reduced the rate of developing type 2 diabetes by 34 percent compared with placebo in people at high risk for the disease, researchers conclude based on 10 years of data.
Research: Migraine and cardiovascular disease: Systematic review and meta-analysis
Migraine with aura (temporary visual or sensory disturbances before or during a migraine headache) is associated with a twofold increased risk of stroke, finds a study published on bmj.com today.
Web-based nutrition program reduces health care costs for employees with cardiac risk factors
Researchers from Boston University School of Medicine (BUSM) and Boston University School of Public Health (BUSPH) have shown that an employer-sponsored, internet-based diet and exercise program shows promise as a low-cost benefit to lower healthcare costs for those at higher risk for above-average costs and healthcare utilization such as cardiac, hyperlipidemia, hypertension or diabetes patients. These findings appear in the current issue of the Journal of Medical Internet Research.
Experts unveil new CVD guidelines and position papers
Several new guidelines and position papers offering the most up to date information to ensure that clinicians practice evidence-based medicine were released at the Canadian Cardiovascular Congress 2009 this week.
Puberty a gateway to heart disease for Canada's teens
A seven-year ongoing study examining over 20,000 Canadian grade 9 students shows most already have at least one major risk factor for heart disease and stroke, Dr. Brian McCrindle told the Canadian Cardiovascular Congress 2009, co-hosted by the Heart and Stroke Foundation and the Canadian Cardiovascular Society.
More Cardiovascular Risk Current Events and Cardiovascular Risk News Articles
 |
Clinical Management of Cardiovascular Risk Factors in Diabetes by Moser Marvin (Author), James R. Sowers (Author) Presents the rationale for why physicians should more aggressively treat hypertension and other CV risk factors in their diabetic patients. Specific therapeutic regimens for reducing CV events in diabetic patients are presented, including BP lowering, management of lipid abnormalities, antiplatelet therapy, and glucose control. |
 |
Reducing The Risk Of Cardiovascular Disease Dr. Andrew Weil (Primary Contributor) |
|
Managing Your Cardiovascular Risk Factors (Mayo Clinic Patient Education) Closed Captioned DVD. | |
 |
Best Cardiovascular Support - 60 Vcaps., (Doctor's Best) by HerbalLoveShop Science-Based Nutrition Featuring Flavoxine Helps Maintain Cholesterol Levels Already in the Normal Range Enhances Cardiovascular Function Dietary Supplement Flavoxine is a new, all natural patented proprietary combination of extracts from Citrus and Phellodendron amurense. Animal studies have shown that the ingredients in Flavoxine possess beneficial effects on heart function and support the maintenance of healthy levels of cholesterol. Supplementation with Flavoxine in a double-blind, placebo-controlled human clinical trial also resulted in significant benefits to cardiovascular health and cholesterol maintenance. Helps Maintain Cholesterol Levels Already in the Normal Range Promotes Healthy Heart Function |
 |
Cardiovascular Risk Management by Richard Hobbs (Author), Bruce Arroll (Author) Practical ABC style Enables doctors to prioritise treatment using risk-scoring systems and holistic recommendations for reducing cardiovascular risk Includes treatment plans for individuals with diabetes, who are at high risk of developing cardiovascular disease How to reduce cardiovascular risk in other specific patient groups Developed by expert groups in different regions of the world |
|
Cardiovascular Risk Abstracts by Euromed Communications | |
 |
Clinical Manual of Total Cardiovascular Risk by Neil R. Poulter (Author) The etiology of coronary heart disease and stroke has been known for decades to be multifactorial - an increasing risk of both CHD and stroke has been shown to have a graded continuous relationship with rising BP and total cholesterol across the whole BP and cholesterol ranges. The coexistance of other risk factors, such as smoking, obesity and age, has been shown to result in a dramatically increased risk. Alongside the numerous risk factors themselves, there is an ever increasing number of papers published aiming to stratify the risk factors. With an also increasing number of guidelines published, there is the need to simplify all of these data into a simple manual. "Clinician's Manual of Total Cardiovascular Risk" provides rapid answers to common clinical questions relating to... |
 |
Therapeutic Strategies in Cardiovascular Risk by Ian M. Graham (Editor), Ralph B. D'Agostino (Editor) The multi-factorial nature of cardiovascular disease has important implications for the planning of effective treatment strategies. Lifestyle factors such as diet, smoking history and exercise combine with endogenous predictors such as ethnicity and family history to give every individual a unique risk profile. To achieve a better outcome for the patient, we first need to understand how these factors work, singly and in combination, to cause or accelerate progression of disease. With this knowledge, we can then develop more effective strategies for management that incorporate changes in lifestyle as well as pharmacological combination therapy for hypertension, dyslipidaemia, etc. In this volume, the authors demonstrate how an ability to measure and quantify risk enables us to isolate key... |
 |
Atherosclerosis, Large Arteries and Cardiovascular Risk (Advances in Cardiology) by Michel E. Safar (Editor), Edward D. Frohlich (Editor) This book presents the current thinking of international experts regarding the underlying mechanisms of cardiovascular risk as well as the pathogenesis and pathophysiology of impaired large arterial stiffness and reduced large arterial distensibility. It also demonstrates the rationale for the present approach to the management and treatment of hypertensive diseases and atherosclerosis. The targeted readership includes basic scientists in vascular physiology as well as physicians and scientists in cardiovascular medicine, diabetes mellitus and renal diseases. |
|
National Guidelines and Tools for Cardiovascular Risk Reduction: A Pocket Guide by Mary Ann Champagne (Author) |
| © 2009 BrightSurf.com |